Anne-Vibeke Lænkholm
Clinical Associate Professor
- Published
The histology at various stages of acute rejection in concordant xenogeneic heart transplantation. A sequential study in rodents
Nielsen, B., Steinbrüchel, D. A., Lænkholm, Anne-Vibeke & Kemp, E., Mar 1992, The histology at various stages of acute rejection in concordant xenogeneic heart transplantation. A sequential study in rodents. 3 ed. Vol. 100. p. 249-55 7 p. (APMIS Supplementum).Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review
- Published
The histology at various stages of acute rejection in concordant xenogeneic heart transplantation. A sequential study in rodents
Nielsen, B., Steinbrüchel, D. A., Lænkholm, Anne-Vibeke & Kemp, E., Mar 1992, In: APMIS Supplementum. 100, 3, p. 249-55 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The immune microenvironment and relation to outcome in patients with advanced breast cancer treated with docetaxel with or without gemcitabine
Stovgaard, E. S., Asleh, K., Riaz, N., Leung, S., Gao, D., Nielsen, L. B., Lænkholm, Anne-Vibeke, Balslev, E., Jensen, M. B., Nielsen, D. & O Nielsen, T., 2021, In: OncoImmunology. 10, 1, 11 p., 1924492.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice
Gonzalez-Ericsson, P. I., Stovgaard, E. S., Sua, L. F., Reisenbichler, E., Kos, Z., Carter, J. M., Michiels, S., Le Quesne, J., Nielsen, T. O., Lænkholm, A. V., Fox, S. B., Adam, J., Bartlett, J. M. S., Rimm, D. L., Quinn, C., Peeters, D., Dieci, M. V., Vincent-Salomon, A., Cree, I., Hida, A. I. & 55 others, , 2020, In: Journal of Pathology. 250, 5, p. 667-684Research output: Contribution to journal › Review › Research › peer-review
- Published
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
El Bairi, K., Haynes, H. R., Blackley, E., Fineberg, S., Shear, J., Turner, S., de Freitas, J. R., Sur, D., Amendola, L. C., Gharib, M., Kallala, A., Arun, I., Azmoudeh-Ardalan, F., Fujimoto, L., Sua, L. F., Liu, S. W., Lien, H. C., Kirtani, P., Balancin, M., El Attar, H. & 31 others, , 2021, In: npj Breast Cancer. 7, 1, 17 p., 150.Research output: Contribution to journal › Review › Research › peer-review
- Published
Tumour-infiltrating CD4-, CD8- and FOXP3-positive immune cells as predictive markers of mortality in BRCA1- and BRCA2-associated breast cancer
Jørgensen, N., Hviid, Thomas Vauvert F., Nielsen, L. B., Sønderstrup, I. M. H., Eriksen, J. O., Ejlertsen, Bent Laursen, Gerdes, Anne-Marie Axø, Kruse, T. A., Thomassen, M., Jensen, M. & Lænkholm, Anne-Vibeke, Aug 2021, In: British Journal of Cancer. 125, p. 1388–1398Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Tumour-infiltrating lymphocytes and response to neoadjuvant letrozole in patients with early oestrogen receptor-positive breast cancer: analysis from a nationwide phase II DBCG trial
Skriver, S. K., Jensen, M., Knoop, A. S., Ejlertsen, Bent Laursen & Lænkholm, Anne-Vibeke, 14 May 2020, In: Breast cancer research : BCR. 22, 1, 8 p., 46.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Validation of prediction of local recurrence (LR) by Prosigna® (PAM50) in a Danish breast cancer cooperative group (DBCG) cohort of hormone receptor positive (HR+), postmenopausal early breast cancer (EBC) patients allocated to 5yr of endocrine therapy (ET)
Eriksen, J. O., Jensen, M., Lænkholm, Anne-Vibeke, Kibøll, T., Rasmussen, B. B., Knoop, A. S., Ferree, S., Haffner, T., Buckingham, W., Schaper, C. & Ejlertsen, B., 2016, In: Cancer Research. 76, 4 Supplement, 1 p., P2-08-10.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
- Published
Williams syndrome transcription factor (WSTF) acts as an activator of estrogen receptor signaling in breast cancer cells and the effect can be abrogated by 1α,25-dihydroxyvitamin D3
Lundqvist, J., Kirkegaard, T., Lænkholm, Anne-Vibeke, Duun-Henriksen, A. K., Bak, M., Feldman, D. & Lykkesfeldt, A. E., 2018, In: The Journal of Steroid Biochemistry and Molecular Biology. 177, p. 171-178Research output: Contribution to journal › Journal article › Research › peer-review
ID: 102813499
Most downloads
-
94
downloads
Identification of metastasis driver genes by massive parallel sequencing of successive steps of breast cancer progression
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
82
downloads
Genomic Analyses of Breast Cancer Progression Reveal Distinct Routes of Metastasis Emergence
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
82
downloads
The Prosigna gene expression assay and responsiveness to adjuvant cyclophosphamide-based chemotherapy in premenopausal high-risk patients with breast cancer
Research output: Contribution to journal › Journal article › Research › peer-review
Published